These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12857569)

  • 61. Necrotizing herpetic retinopathy in kidney-transplanted patients on mycophenolate mofetil.
    Morión Grande M; Martín-Gómez MA; Quereda Castañeda A; López Jiménez V; Cabezas Fernández T
    Nefrologia; 2016; 36(5):575-577. PubMed ID: 27577044
    [No Abstract]   [Full Text] [Related]  

  • 62. Effects of histone deacetylase inhibitors on alloresponses.
    Hancock WW
    Lancet Oncol; 2014 Jan; 15(1):10-1. PubMed ID: 24295573
    [No Abstract]   [Full Text] [Related]  

  • 63. [Mycophenolate mofetil: an alternative treatment for refractory autoimmune hemolytic anemia in children].
    Navarro Mingorance A; Jimenez García I; Galera Miñarro AM; Fuster Soler JL
    An Pediatr (Barc); 2012 Jul; 77(1):64-5. PubMed ID: 22483537
    [No Abstract]   [Full Text] [Related]  

  • 64. Treatment of severe lichen planus with mycophenolate mofetil.
    Frieling U; Bonsmann G; Schwarz T; Luger TA; Beissert S
    J Am Acad Dermatol; 2003 Dec; 49(6):1063-6. PubMed ID: 14639385
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation.
    Mori Y; Yoshimoto G; Yuda JI; Hayashi M; Odawara J; Kuriyama T; Sugio T; Miyawaki K; Kamezaki K; Kato K; Takenaka K; Iwasaki H; Maeda T; Miyamoto T; Akashi K
    Leuk Lymphoma; 2019 Jan; 60(1):271-273. PubMed ID: 29741437
    [No Abstract]   [Full Text] [Related]  

  • 66. [Complications of hematopoietic stem cell transplantation and the treatment: graft-versus-host disease].
    Kato A
    Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1337-43. PubMed ID: 16097589
    [No Abstract]   [Full Text] [Related]  

  • 67. The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum.
    Nousari HC; Lynch W; Anhalt GJ; Petri M
    Arch Dermatol; 1998 Dec; 134(12):1509-11. PubMed ID: 9875186
    [No Abstract]   [Full Text] [Related]  

  • 68. The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study.
    van Dorp S; Resemann H; te Boome L; Pietersma F; van Baarle D; Gmelig-Meyling F; de Weger R; Petersen E; Minnema M; Lokhorst H; Ebeling S; Beijn SJ; Knol EF; van Dijk M; Meijer E; Kuball J
    Haematologica; 2011 Sep; 96(9):1380-4. PubMed ID: 21546493
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets.
    Zeiser R; Blazar BR
    N Engl J Med; 2017 Dec; 377(26):2565-2579. PubMed ID: 29281578
    [No Abstract]   [Full Text] [Related]  

  • 70. Neonatal anemia and hydrops fetalis after maternal mycophenolate mofetil use.
    Tjeertes IF; Bastiaans DE; van Ganzewinkel CJ; Zegers SH
    J Perinatol; 2007 Jan; 27(1):62-4. PubMed ID: 17180133
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chronic diarrhoea from mycophenolate mofetil-induced colitis.
    Gorospe EC
    BMJ Case Rep; 2012 Mar; 2012():. PubMed ID: 22605606
    [No Abstract]   [Full Text] [Related]  

  • 72. Preventing Graft-Versus-Host Disease Without Losing Graft-Versus-Leukemia Effect After Allogeneic Stem-Cell Transplantation.
    Kröger N
    J Clin Oncol; 2020 Oct; 38(29):3357-3360. PubMed ID: 32706637
    [No Abstract]   [Full Text] [Related]  

  • 73. Cervical and vaginal cancer in a woman with chronic graft-versus-host disease.
    Bolla D; Ruhstaller T; Diener PA; Lang F; Hornung R
    Int J Gynaecol Obstet; 2011 Aug; 114(2):159-60. PubMed ID: 21669422
    [No Abstract]   [Full Text] [Related]  

  • 74. Pathology of Gastrointestinal and Liver Complications of Hematopoietic Stem Cell Transplantation.
    Mourad N; Michel RP; Marcus VA
    Arch Pathol Lab Med; 2019 Sep; 143(9):1131-1143. PubMed ID: 30838881
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Blaschkolinear Lichen Planus Pigmentosus in the Setting of Chronic Graft-versus-host Disease.
    Pinzani C; Bouaziz JD
    Acta Derm Venereol; 2019 Feb; 99(2):218-219. PubMed ID: 30328472
    [No Abstract]   [Full Text] [Related]  

  • 76. Pericardial constriction attributable to graft-versus-host disease: importance of early immunosuppression.
    Morley-Smith AC; Cowie MR; Vazir A
    Circ Heart Fail; 2013 Sep; 6(5):e59-61. PubMed ID: 24046478
    [No Abstract]   [Full Text] [Related]  

  • 77. Periorbital lupuslike presentation of graft-versus-host disease.
    Kaffenberger J; Helm K; Miller J
    Cutis; 2018 Jan; 101(1):E28-E29. PubMed ID: 29529116
    [No Abstract]   [Full Text] [Related]  

  • 78. Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.
    Martin PJ; Storer BE; Carpenter PA; Couriel DR; Flowers ME; Gupta V; Hsu JW; Jagasia M; Kitko CL; Maziarz RT; Rowley SD; Shaughnessy PJ; van Besien K; Weisdorf D; Lee SJ
    Biol Blood Marrow Transplant; 2011 Jan; 17(1):124-32. PubMed ID: 20601033
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ruxolitinib as a promising treatment for corticosteroid-refractory graft-versus-host disease.
    Assouan D; Lebon D; Charbonnier A; Royer B; Marolleau JP; Gruson B
    Br J Haematol; 2018 Jun; 181(5):687-689. PubMed ID: 28444730
    [No Abstract]   [Full Text] [Related]  

  • 80. [Diagnosis and management of chronic graft-versus-host disease].
    Inamoto Y
    Rinsho Ketsueki; 2014 Oct; 55(10):2113-24. PubMed ID: 25297778
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.